William J. Newell - 03 Mar 2023 Form 4 Insider Report for SUTRO BIOPHARMA, INC. (STRO)

Role
CEO, Director
Signature
/s/ Edward C. Albini as attorney-in-fact for William J. Newell
Issuer symbol
STRO
Transactions as of
03 Mar 2023
Net transactions value
-$99,854
Form type
4
Filing time
07 Mar 2023, 15:56:56 UTC
Previous filing
31 Jan 2023
Next filing
31 Jan 2024
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction STRO Common Stock Options Exercise +31,125 +24% 163,312 03 Mar 2023 Direct F1
transaction STRO Common Stock Options Exercise +18,750 +11% 182,062 03 Mar 2023 Direct F1
transaction STRO Common Stock Tax liability $99,854 -17,246 -9.5% $5.79 164,816 03 Mar 2023 Direct F2
holding STRO Common Stock 116,525 03 Mar 2023 By William J. Newell Family Trust DTD 03/15/2019 F3

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction STRO Stock Option (right to buy Common Stock) Award $0 +125,000 $0.000000 125,000 03 Mar 2023 Common Stock 125,000 $5.79 Direct F4
transaction STRO Restricted Stock Unit (RSU) Award $0 +95,000 $0.000000 95,000 03 Mar 2023 Common Stock 95,000 Direct F1, F5
transaction STRO Restricted Stock Unit (RSU) Options Exercise $0 -31,125 -25% $0.000000 93,375 03 Mar 2023 Common Stock 31,125 Direct F1, F6
transaction STRO Restricted Stock Unit (RSU) Options Exercise $0 -18,750 -33% $0.000000 37,500 03 Mar 2023 Common Stock 18,750 Direct F1, F7
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Each RSU represents a contingent right to receive one (1) share of the issuer's Common Stock upon settlement.
F2 Represents the number of shares of Common Stock that have been withheld by the issuer to satisfy its income tax withholding and remittance obligations in connection with the net settlement of the RSUs and does not represent a sale by the reporting person.
F3 The securities are held of record by the reporting person as trustee of the William J. Newell Family Trust DTD 03/15/2019.
F4 The option vests as to 2.0833% of the total shares monthly, beginning on April 1, 2023, with 100% of the total shares vested and exercisable on March 1, 2027, subject to the reporting person's provision of service to the issuer on each vesting date.
F5 The RSUs vest as to 1/4th of the total shares annually beginning on March 1, 2024, subject to continued service through each vesting date.
F6 The RSUs vest as to 1/4th of the total shares annually beginning on March 4, 2023, subject to continued service through each vesting date.
F7 The RSUs vest as to 1/4th of the total shares annually beginning on March 5, 2022, subject to continued service through each vesting date.